1.
|
Phase: Phase II Type: Treatment Status: Closed Age: 25 to 100 Sponsor: Other Protocol IDs: CDR0000315451, CSMC-IRB-4107-01, NCT00064376
|
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000441212, RPCI-I-23204, ABBOTT-RPCI-I-23204, I 23204, NCT00217477
|
|
3.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000583652, P30CA012197, CCCWFU-74307, NCT00637897
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 54110, NCI-2011-02409, NCT01197664
|